Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial biofilm and dental enamel interface is a complex biological environment that serves as the primary site for the pathogenesis of dental caries and periodontal diseases [1, 5]. Dental enamel, a highly mineralized tissue composed of hydroxyapatite, provides the structural foundation for the attachment of the acquired salivary pellicle and subsequent microbial colonization [5]. The resulting dental plaque is a mature biofilm characterized by a protective extracellular polymeric substance (EPS) matrix that harbors diverse microbial species, including acidogenic bacteria like Streptococcus mutans [1, 7]. These microorganisms ferment dietary sugars to produce organic acids, which lower the local pH and drive the demineralization of the enamel surface [1, 3]. Therapeutic strategies targeting this interface include the use of fluoride to enhance remineralization and form acid-resistant fluorapatite, as well as antimicrobials like chlorhexidine to reduce bacterial load and disrupt biofilm architecture [3, 7]. Emerging research focuses on precision therapies such as quorum-sensing inhibitors and matrix-degrading enzymes to manage the oral microbiome without causing widespread dysbiosis [7, 9]. Understanding the dynamic balance between demineralization and remineralization at this interface is critical for the development of effective oral health treatments [3, 6].
Inhibition of bacterial acid production, disruption of extracellular polymeric substance (EPS) matrix, promotion of hydroxyapatite remineralization, and bactericidal/bacteriostatic activity.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial biofilm and dental enamel.